Bleeding / Hemorrhage

Uncontrollable blood loss is a leading cause of death on the battlefield and the operating table alike. Researchers at the Feinstein have developed the neural tourniquet, a bioelectronic medical device that uses electronic nerve stimulation to slow blood loss. They have found that using as little as 60 seconds of electrical stimulation to neural pathways to the spleen is sufficient to prepare the body for clotting in the event of a wound. By priming the body’s coagulation system, it is able to clot 50 percent more rapidly and reduce the volume of blood loss by 50 percent. The neural tourniquet is applicable to a range of life-saving scenarios: to the more than 50 million planned surgeries taking place in America each year; to accident scenes where first responders treat bleeding trauma victims; and on the battlefield treating the blood loss of wounded service men and women. To bring the neural tourniquet to market, the Feinstein has partnered with Battelle, a leading non-profit scientific research and development lab. We anticipate that early models of the device will be available within three to five years.

Select Publications: